Posts Tagged ‘ISCI’
Colon Cancer in Young Adults: Know Your Risk
Timothy L. Cannon, MD, is a member of Inova Medical Group board certified in medical oncology and hematology. He has a special interest in managing of gastrointestinal cancers. Read Dr. Cannon’s profile. March is Colorectal Cancer Awareness Month, and I always applaud efforts to raise awareness of this disease – the fourth most common cancer…
Read MoreInova Schar Cancer Institute Oncologist Jeanny Aragon-Ching Selected for ASCO Leadership Development Program
FALLS CHURCH, VA – Inova is pleased to announce that Jeanny Aragon-Ching, MD, has been selected to participate in the esteemed American Society of Clinical Oncology (ASCO) Leadership Development Program for years 2017-2018. The ASCO Leadership Development Program is a year-long course for a mid-career group of highly accomplished practicing oncologists. It positions them to…
Read MoreSexual Health, Intimacy, and Metastatic Disease: Reclaiming Your Sexual Self, BreastCancer.org
Sage Bolte, PhD, sat down with Breastcancer.org to discuss how women with metastic disease can reclaim their sexual self. Read more.
Read MoreFrom Research to Results: Advances in Genitourinary Cancer Treatment
Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Read Dr. Aragon-Ching’s profile. This February, I’ll be traveling to…
Read MoreWhy Inova is getting into the drug discovery business, Washington Business Journal, December 13, 2016
Inova’s drug discovery program is yet another component of the hospital’s broader ambitions to create a nationally recognized precision medicine and cancer care center. Read more.
Read MoreInova Leaders in Gynecologic Cancer and Proteomic Research to Spearhead Cancer Moonshot’s APOLLO Program
APOLLO will accelerate the understanding and application of proteogenomics in cancer treatment FALLS CHURCH, VA – October 17, 2016 – Earlier today, Vice President Joe Biden and Dr. Jill Biden announced updates related to the federal Moonshot for Cancer program, which aims to make a decade’s worth of progress in the fight against cancer in…
Read MoreInova Names Michael Maitland, M.D, Ph.D., Director of Therapeutics for the Inova Center for Personalized Health
Maitland will also serve as Associate Director of Cancer Therapeutics for the Inova Schar Cancer FALLS CHURCH, VA – August 16, 2016 – Inova Health System is pleased to welcome Michael Maitland, M.D., Ph.D., where he will serve as the new Director of Therapeutics for the Inova Center for Personalized Health (ICPH) and as Associate Director…
Read MoreIn advance of World Ovarian Cancer Day, Inova Celebrates Receipt of Phase II Funding for the Consortium for Long-Term Survival from the Department of Defense Ovarian Cancer Research Program
Inova partners with coordinating center Massachusetts General Hospital and 14 other institutions to increase long-term survival rates for ovarian cancer patients. FALLS CHURCH, VA – May 6, 2016 – The Inova Schar Cancer Institute announces today, coinciding with World Ovarian Cancer Day, that the Consortium for Long-Term Survival has received Phase II funding. The consortium, co-led…
Read MoreMedical Oncology & Hematology Associates of Northern Virginia Joins Inova Medical Group
FALLS CHURCH, VA – February 16, 2016 – Inova Medical Group this month announced that Medical Oncology & Hematology Associates of Northern Virginia will join its team of talented and experienced physicians employed by Inova. The practice, which brings five physicians, four nurse practitioners or physician assistants, and more than 50 support staff members, will have…
Read MoreInova Dwight and Martha Schar Cancer Institute Names Leading Experts in Cancer Care, Research and Administration
Inova Dwight and Martha Schar Cancer Institute (ISCI) names Jeanny Aragon-Ching, MD, Clinical Program Director of Genitourinary Cancers and (ISCI) names Thomas Graves, FACHE, Vice President for Cancer Services and ISCI Associate Director for Administration FALLS CHURCH, VA – October 28, 2015 – Inova today announced the addition of two leaders who will bring new…
Read More